Welcome to the Institute of Clinical Neuroimmunology
News
Klaus Faber Initiative for Progressive MS prolonged at the Institute of Clinical Neuroimmunology
Work of Lisa Gerdes and colleagues named by the Süddeutsche Zeitung as 2024 breakthrough
March 2025: Based on promising findings on the immune mechanisms that drive progression in multiple sclerosis (MS) the Klaus Faber foundation has prolonged their funding for a research initiative at the Institute of Clinical Neuroimmunology.
January 2025: The Süddeutsche Zeitung selects work by Lisa Gerdes and colleagues as a breakthrough discovery for 2024.
LMU researchers demonstrate that certain immune cells already play an important role in the early stages of multiple sclerosis
Fluorogenic chemical probes for wash-free imaging of cell membrane damage in ferroptosis, necrosis and axon injury
September 2024 – Here the Gerdes lab together with the Beltran lab analyzed CD8 T cells from the blood and cerebrospinal fluid of monozygotic twins, where one twin had MS and the other showed no signs or subclinical signs of neuroinflammation (SCNI). The Study demonstrates that CD8 T ...
April 2024 – Membrane damage is key step in the pathological cascade that leads to neuronal death or axon degeneration. Here, the Kerschensteiner lab worked together with a research team headed by Oliver Thorn-Seshold at the LMU Department of Pharmacy to develop new modular ....
